Prokidney Corp Stock Alpha and Beta Analysis
| PROK Stock | USD 0.98 0.03 3.16% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as ProKidney Corp. It also helps investors analyze the systematic and unsystematic risks associated with investing in ProKidney Corp over a specified time horizon. Remember, high ProKidney Corp's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to ProKidney Corp's market risk premium analysis include:
Beta 1.56 | Alpha (0.71) | Risk 5.01 | Sharpe Ratio (0.18) | Expected Return (0.92) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
ProKidney |
ProKidney Corp Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. ProKidney Corp market risk premium is the additional return an investor will receive from holding ProKidney Corp long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in ProKidney Corp. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate ProKidney Corp's performance over market.| α | -0.71 | β | 1.56 |
ProKidney Corp expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of ProKidney Corp's Buy-and-hold return. Our buy-and-hold chart shows how ProKidney Corp performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.ProKidney Corp Market Price Analysis
Market price analysis indicators help investors to evaluate how ProKidney Corp stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading ProKidney Corp shares will generate the highest return on investment. By understating and applying ProKidney Corp stock market price indicators, traders can identify ProKidney Corp position entry and exit signals to maximize returns.
ProKidney Corp Return and Market Media
The median price of ProKidney Corp for the period between Sun, Dec 15, 2024 and Sat, Mar 15, 2025 is 1.62 with a coefficient of variation of 17.44. The daily time series for the period is distributed with a sample standard deviation of 0.27, arithmetic mean of 1.58, and mean deviation of 0.2. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | ProKidney Shares Down 4.8 percent - Heres Why - MarketBeat | 12/18/2024 |
2 | Acquisition by Fox Jennifer A. of 42515 shares of ProKidney Corp at 10.92 subject to Rule 16b-3 | 12/27/2024 |
3 | ProKidney Shares Gap Up - Time to Buy - MarketBeat | 12/31/2024 |
4 | Head-To-Head Contrast ProKidney and Cortexyme | 01/06/2025 |
5 | Insiders In ProKidney Still Down 26 percent On US54.7m Investment | 01/22/2025 |
6 | Kuehn Law Encourages Investors of ProKidney Corp. to Contact Law Firm - Morningstar | 01/31/2025 |
7 | Acquisition by Pereira Brian Jg of 81928 shares of ProKidney Corp subject to Rule 16b-3 | 02/04/2025 |
8 | Disposition of 81928 shares by Pereira Brian Jg of ProKidney Corp subject to Rule 16b-3 | 02/06/2025 |
9 | Owning 32 percent shares,institutional owners seem interested in ProKidney Corp. , | 02/25/2025 |
10 | Disposition of 748952 shares by Legorreta Pablo G. of ProKidney Corp subject to Rule 16b-3 | 02/27/2025 |
11 | Acquisition by Coulston James of 650000 shares of ProKidney Corp at 1.23 subject to Rule 16b-3 | 02/28/2025 |
12 | Disposition of 675234 shares by Pereira Brian Jg of ProKidney Corp subject to Rule 16b-3 | 03/07/2025 |
13 | Top 3 Health Care Stocks Youll Regret Missing This Quarter - Benzinga | 03/13/2025 |
About ProKidney Corp Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including ProKidney or other stocks. Alpha measures the amount that position in ProKidney Corp has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2022 | 2024 | 2025 (projected) | Net Debt To EBITDA | 3.39 | 0.34 | 0.33 | Intangibles To Total Assets | 4.11E-4 | 4.73E-4 | 4.49E-4 |
ProKidney Corp Upcoming Company Events
As portrayed in its financial statements, the presentation of ProKidney Corp's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, ProKidney Corp's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of ProKidney Corp's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of ProKidney Corp. Please utilize our Beneish M Score to check the likelihood of ProKidney Corp's management manipulating its earnings.
| 26th of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 26th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with ProKidney Corp
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out ProKidney Corp Backtesting, ProKidney Corp Valuation, ProKidney Corp Correlation, ProKidney Corp Hype Analysis, ProKidney Corp Volatility, ProKidney Corp History and analyze ProKidney Corp Performance. For more information on how to buy ProKidney Stock please use our How to buy in ProKidney Stock guide.You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
ProKidney Corp technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.